Home › Calculator › CSPCY Dividend Calculator 2026
CSPCY DRIP Calculator & Dividend Yield 2026
3.48% YieldHealthcareCSPC Pharmaceutical Group Limited · OTC
Price: $4.26 · Annual div: $0.1483/share · Frequency: semi-annual · Payout ratio: 11% · Ex-div: 2026-10-21
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CSPCY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
CSPCY Dividend History — Last 15 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-10-21Latest | 2026-11-25 | $0.0918 | 3.23% | $5.21 |
| 2026-06-25 | 2026-07-29 | $0.0765 | 3.81% | $3.89 |
| 2025-10-20 | 2025-12-03 | $0.0718 | 4.32% | $4.76 |
| 2025-06-05 | 2025-08-01 | $0.0514 | 3.52% | $3.79 |
| 2024-11-01 | 2024-12-05 | $0.0821 | 5.82% | $2.64 |
| 2024-06-03 | 2024-07-11 | $0.0716 | 5.98% | $3.33 |
| 2023-09-07 | 2023-10-26 | $0.0715 | 5.95% | $3.00 |
| 2023-06-05 | 2023-07-13 | $0.0561 | 3.14% | $3.41 |
| 2022-09-08 | 2022-10-25 | $0.0510 | 3.54% | $4.04 |
| 2022-05-31 | 2022-07-07 | $0.0510 | 2.34% | $3.93 |
| 2021-09-10 | 2021-10-25 | $0.0411 | 1.70% | $5.15 |
| 2021-05-24 | 2021-06-25 | $0.0464 | 2.15% | $4.90 |
| 2020-09-09 | 2020-10-26 | $0.0155 | — | — |
| 2020-06-18 | 2020-07-17 | $0.0433 | — | — |
| 2019-05-29 | 2019-06-28 | $0.0384 | — | — |
About CSPC Pharmaceutical Group Limited (CSPCY) — Dividend Analysis 2026
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. It also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, the company provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food products; and healthcare services. It has a strategic collaboration with AstraZeneca PLC to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications and multiple therapies for obesity and type 2 diabetes. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.
Similar dividend stocks to CSPCY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CSPCY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CSPCY position with:
🌍 CSPCY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CSPCY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.48% | 0.68% | $348 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.96% | 0.16% | $296 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.78% | -0.02% | $278 / yr |
| 🇬🇧 UK ISA | 0% | 3.48% | 0.68% | $348 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.18% | 0.38% | $318 / yr |
| 🇨🇦 TFSA | 0% | 3.48% | 0.68% | $348 / yr |
| 🇨🇦 CA Taxable | 25% | 2.61% | -0.19% | $261 / yr |
| 🇦🇺 Super (pension) | 15% | 2.96% | 0.16% | $296 / yr |
| 🇦🇺 AU Taxable | 30% | 2.44% | -0.36% | $244 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.56% | -0.24% | $256 / yr |
| 🇫🇷 FR Taxable | 30% | 2.44% | -0.36% | $244 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CSPCY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.15/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CSPCY Dividend Payment Schedule
CSPCY pays quarterly — 4 times per year. Ex-div: 2026-10-21.
📊 CSPCY vs Healthcare Benchmarks
How CSPCY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CSPCY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CSPCY Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare CSPCY with peers: CSPCY vs BSPM · CSPCY vs CHME · CSPCY vs CPHI
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CSPCY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CSPC Pharmaceutical Group Limited (CSPCY) is currently trading at $4.26, 22% below its 52-week high. The current dividend yield is 3.48% based on an annual payout of $0.1483 per share.
CSPCY (CSPC Pharmaceutical Group Limited) — 3.48% Dividend Yield Analysis
CSPC Pharmaceutical Group Limited (CSPCY) is a healthcare stock currently trading at $4.26 with a dividend yield of 3.48%. It pays an annual dividend of $0.1483 per share. The payout ratio of 11% suggests the dividend is well-covered by earnings. Over the past 5 years, CSPCY has grown its dividend at a compound annual rate of 15.2%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CSPCY News
LiveHow investors use the CSPCY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.